Elicio Therapeutics, Inc.
ELTXCIK 0001601485 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 29, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0018
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Elicio Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Connelly Robert | OfficerDirector | 4 |
| Haqq Christopher | Officer | 4 |
| Wilson Karen J | Director | 4 |
| Adams Julian | Director | 3 |
| Ashe Carol Gail | Director | 3 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Elicio Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Venkatesan Jay | 3 | 0% | -19.3% | -19.8% | -17.9% | -20.3% |
All filings
61 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|